| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Negar Molazadeh, Gauruv Bose, Itay Lotan, Michael Lev. Autoimmune diseases and cancers overlapping with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review. Multiple sclerosis journal - experimental, translational and clinical. vol 8. issue 4. 2022-10-31. PMID:36311694. |
myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) has various similarities with aqp4-igg-seropositive neuromyelitis optica spectrum disorder (aqp4-igg + nmosd) in terms of clinical presentations, magnetic resonance imaging (mri) findings, and response to treatment. |
2022-10-31 |
2023-08-14 |
Not clear |
| Zina Alme. [OPTIC NEURITIS - CLASSIFICATION, MANAGEMENT AND TREATMENT]. Harefuah. vol 161. issue 10. 2022-10-31. PMID:36315205. |
the understanding and the classification of atypical optic neuritis evolved significantly since the discovery of the anti-aquaporin4 (aqp4) and the anti-myelin oligodendrocyte glycoprotein (mog) antibodies as biomarkers and pathologic causes of neuromyelitis optica spectrum disorder (nmosd) and mog-associated disorder (mogad) respectively. |
2022-10-31 |
2023-08-14 |
Not clear |
| Gregorio Spagni, Bo Sun, Gabriele Monte, Elia Sechi, Raffaele Iorio, Amelia Evoli, Valentina Damat. Efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. Journal of neurology, neurosurgery, and psychiatry. 2022-10-25. PMID:36283808. |
efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. |
2022-10-25 |
2023-08-14 |
Not clear |
| Gregorio Spagni, Bo Sun, Gabriele Monte, Elia Sechi, Raffaele Iorio, Amelia Evoli, Valentina Damat. Efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. Journal of neurology, neurosurgery, and psychiatry. 2022-10-25. PMID:36283808. |
rituximab (rtx) efficacy in patients with myelin oligodendrocyte glycoprotein (mog) antibody-associated disorders (mogads) is still poorly understood, though it appears to be lower than in aquaporin-4-igg-positive neuromyelitis optica spectrum disorders (aqp4-igg+nmosds). |
2022-10-25 |
2023-08-14 |
Not clear |
| Busayanut Puangsricharoen, Kavin Vanikieti, Panitha Jindahra, Tanyatuth Padungkiatsagu. Serum Vitamin D Levels and Status in Thai Optic Neuritis Subjects: A Case-Control Study. Clinical ophthalmology (Auckland, N.Z.). vol 16. 2022-10-17. PMID:36249444. |
to measure serum total vitamin d or 25-hydroxyvitamin d [25(oh)d] levels and status in immune-based optic neuritis (on) including neuromyelitis optica spectrum disorder (nmosd)-on, myelin oligodendrocyte glycoprotein antibody-associated disease (mogad)-on, autoimmune-on, and idiopathic-on and compare them with age- and sex-matched healthy controls. |
2022-10-17 |
2023-08-14 |
human |
| Jonathan A Gernert, Rebecca Wicklein, Bernhard Hemmer, Tania Kümpfel, Benjamin Knier, Joachim Havl. Peripapillary hyper-reflective ovoid mass-like structures (PHOMS) in AQP4-IgG-positive neuromyelitis optica spectrum disease (NMOSD) and MOG-IgG-associated disease (MOGAD). Journal of neurology. 2022-10-16. PMID:36245037. |
currently, no data on the prevalence of phoms in other demyelinating diseases including aquaporine-4-igg-positive neuromyelitis optica spectrum disease (aqp4 + nmosd) or myelin oligodendrocyte glycoprotein-igg-associated disease (mogad) are reported. |
2022-10-16 |
2023-08-14 |
Not clear |
| Paula Barreras, Eleni S Vasileiou, Angeliki G Filippatou, Kathryn C Fitzgerald, Michael Levy, Carlos A Pardo, Scott D Newsome, Ellen M Mowry, Peter A Calabresi, Elias S Sotircho. Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease. Neurology. 2022-10-14. PMID:36240094. |
rituximab is used widely for relapse prevention in neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein (mog)-igg associated disease (mogad), however data regarding the effectiveness and safety of long-term rituximab use in these conditions are limited. |
2022-10-14 |
2023-08-14 |
Not clear |
| Itay Lotan, Shuhei Nishiyama, Giovanna S Manzano, Melissa Lydston, Michael Lev. COVID-19 and the risk of CNS demyelinating diseases: A systematic review. Frontiers in neurology. vol 13. 2022-10-07. PMID:36203986. |
viral infections are a proposed possible cause of inflammatory central nervous system (cns) demyelinating diseases, including multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). |
2022-10-07 |
2023-08-14 |
Not clear |
| Rosa Cortese, Ferran Prados Carrasco, Carmen Tur, Alessia Bianchi, Wallace Brownlee, Floriana De Angelis, Isabel De La Paz, Francesco Grussu, Lukas Haider, Anu Jacob, Baris Kanber, Lise Magnollay, Richard S Nicholas, Anand Trip, Marios Yiannakas, Ahmed T Toosy, Yael Hacohen, Frederik Barkhof, Olga Ciccarell. Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging. Neurology. 2022-10-03. PMID:36192175. |
relapsing remitting multiple sclerosis (rrms), aquaporin4 antibody-positive neuromyelitis optica spectrum disorder (aqp4-nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) may have overlapping clinical features. |
2022-10-03 |
2023-08-14 |
Not clear |
| Maria Schroeder-Castagno, Alba Del Rio-Serrato, Andreas Wilhelm, Silvina Romero-Suárez, Patrick Schindler, Cesar Alvarez-González, Ankelien-Solveig Duchow, Judith Bellmann-Strobl, Klemens Ruprecht, Maria Hastermann, Gerald Grütz, Brigitte Wildemann, Sven Jarius, Tanja Schmitz-Hübsch, Friedemann Paul, Carmen Infante-Duart. Impaired response of blood neutrophils to cell-death stimulus differentiates AQP4-IgG-seropositive NMOSD from MOGAD. Journal of neuroinflammation. vol 19. issue 1. 2022-10-01. PMID:36183103. |
in neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad), neutrophils are found in cns lesions. |
2022-10-01 |
2023-08-14 |
Not clear |
| Axel Petzold, Clare L Fraser, Mathias Abegg, Raed Alroughani, Daniah Alshowaeir, Regina Alvarenga, Cécile Andris, Nasrin Asgari, Yael Barnett, Roberto Battistella, Raed Behbehani, Thomas Berger, Mukharram M Bikbov, Damien Biotti, Valerie Biousse, Antonella Boschi, Milan Brazdil, Andrei Brezhnev, Peter A Calabresi, Monique Cordonnier, Fiona Costello, Franz M Cruz, Leonardo Provetti Cunha, Smail Daoudi, Romain Deschamps, Jerome de Seze, Ricarda Diem, Masoud Etemadifar, Jose Flores-Rivera, Pedro Fonseca, Jette Frederiksen, Elliot Frohman, Teresa Frohman, Caroline Froment Tilikete, Kazuo Fujihara, Alberto Gálvez, Riadh Gouider, Fernando Gracia, Nikolaos Grigoriadis, José M Guajardo, Mario Habek, Marko Hawlina, Elena H Martínez-Lapiscina, Juzar Hooker, Jyh Yung Hor, William Howlett, Yumin Huang-Link, Zhannat Idrissova, Zsolt Illes, Jasna Jancic, Panitha Jindahra, Dimitrios Karussis, Emilia Kerty, Ho Jin Kim, Wolf Lagrèze, Letizia Leocani, Netta Levin, Petra Liskova, Yaou Liu, Youssoufa Maiga, Romain Marignier, Chris McGuigan, Dália Meira, Harold Merle, Mário L R Monteiro, Anand Moodley, Frederico Moura, Silvia Muñoz, Sharik Mustafa, Ichiro Nakashima, Susana Noval, Carlos Oehninger, Olufunmilola Ogun, Afekhide Omoti, Lekha Pandit, Friedemann Paul, Gema Rebolleda, Stephen Reddel, Konrad Rejdak, Robert Rejdak, Alfonso J Rodriguez-Morales, Marie-Bénédicte Rougier, Maria Jose Sa, Bernardo Sanchez-Dalmau, Deanna Saylor, Ismail Shatriah, Aksel Siva, Hadas Stiebel-Kalish, Gabriella Szatmary, Linh Ta, Silvia Tenembaum, Huy Tran, Yevgen Trufanov, Vincent van Pesch, An-Guor Wang, Mike P Wattjes, Ernest Willoughby, Magd Zakaria, Jasmin Zvornicanin, Laura Balcer, Gordon T Plan. Diagnosis and classification of optic neuritis. The Lancet. Neurology. 2022-09-30. PMID:36179757. |
accurate diagnosis of optic neuritis at presentation can facilitate the timely treatment of individuals with multiple sclerosis, neuromyelitis optica spectrum disorder, or myelin oligodendrocyte glycoprotein antibody-associated disease. |
2022-09-30 |
2023-08-14 |
Not clear |
| Mohini Agrawal, Sandeep Shankar, Sunandan Bhatt. Neuromyelitis optica spectrum disorder with negative aquaporin-4 antibodies and positive anti-myelin oligodendrocyte glycoprotein antibodies: A case report. Medical journal, Armed Forces India. vol 78. issue Suppl 1. 2022-09-23. PMID:36147390. |
neuromyelitis optica spectrum disorder with negative aquaporin-4 antibodies and positive anti-myelin oligodendrocyte glycoprotein antibodies: a case report. |
2022-09-23 |
2023-08-14 |
Not clear |
| George Saitakis, Bart K Chwalis. Treatment and Relapse Prevention of Typical and Atypical Optic Neuritis. International journal of molecular sciences. vol 23. issue 17. 2022-09-09. PMID:36077167. |
the atypical spectrum includes entities such as antibody-driven on associated with neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody disease (mogad), chronic/relapsing inflammatory optic neuropathy (crion), and sarcoidosis-associated on. |
2022-09-09 |
2023-08-14 |
Not clear |
| Xiao Fan, Qi Li, Tingsong Li, Xiaoyan He, Chuan Feng, Bin Qin, Ye Xu, Ling H. Radiological Features for Outcomes of MOGAD in Children: A Cohort in Southwest China. Neuropsychiatric disease and treatment. vol 18. 2022-09-02. PMID:36052272. |
studies suggested that myelin oligodendrocyte glycoprotein antibody-associated disorders (mogad) are an isolated group of diseases that are different from multiple sclerosis (ms) and neuromyelitis optica spectrum disorders (nmosd). |
2022-09-02 |
2023-08-14 |
Not clear |
| Yaqing Shu, Xiaoyu Ma, Chen Chen, Yuge Wang, Xiaobo Sun, Liang Zhang, Zhengqi Lu, Frank Petersen, Wei Qiu, Xinhua Y. Myelin oligodendrocyte glycoprotein-associated disease is associated with BANK1, RNASET2 and TNIP1 polymorphisms. Journal of neuroimmunology. vol 372. 2022-09-02. PMID:36054934. |
here we aimed to compare association of common immune-related genetic variants with three autoimmune central nervous system (cns) demyelinating diseases, namely myelin oligodendrocyte glycoprotein-associated disease (mogad), multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (nmosd). |
2022-09-02 |
2023-08-14 |
Not clear |
| Michlene Passeri, Elizabeth Matthews, Ryan Kammeyer, Amanda L Pique. Update in autoimmune and paraneoplastic myelopathies: Newly described antigen targets and antibody testing. Frontiers in neurology. vol 13. 2022-08-15. PMID:35968301. |
while specific features of certain autoimmune myelopathies such as aquaporin-4 antibody associated neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein associated disorder (mogad) are well-characterized, other less commonly seen antibody-associated myelopathies are not as well-defined. |
2022-08-15 |
2023-08-14 |
Not clear |
| Romana Höftberger, Hans Lassmann, Thomas Berger, Markus Reind. Pathogenic autoantibodies in multiple sclerosis - from a simple idea to a complex concept. Nature reviews. Neurology. 2022-08-15. PMID:35970870. |
however, subsequent evidence suggested that some cases originally diagnosed as ms with autoantibody-mediated demyelination were more likely to be neuromyelitis optica spectrum disorder or myelin oligodendrocyte glycoprotein antibody-associated disease. |
2022-08-15 |
2023-08-14 |
Not clear |
| Jang Ho Lee, Yeji Moon, Young Nam Kwon, Jong Hoon Shin, Sung-Min Kim, Jae Ho Jun. Changes of retinal structure and visual function in patients with demyelinating transverse myelitis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2022-08-08. PMID:35939134. |
to identify the retina-structural and visual-functional alterations in the patients with aquaporin-4 (aqp4)-igg-positive neuromyelitis optica spectrum disorder (nmosd), myelin oligodendrocyte glycoprotein-associated disease (mogad), and multiple sclerosis (ms) patients, all of whom had demyelinating transverse myelitis (tm) without optic neuritis (on). |
2022-08-08 |
2023-08-14 |
Not clear |
| Ines El Naggar, Robert Cleaveland, Eva-Maria Wendel, Annikki Bertolini, Kathrin Schanda, Michael Karenfort, Charlotte Thiels, Adela Della Marina, Mareike Schimmel, Steffen Leiz, Christian Lechner, Matthias Baumann, Markus Reindl, Andreas Wegener-Panzer, Kevin Rostás. MR imaging in children with transverse myelitis and acquired demyelinating syndromes. Multiple sclerosis and related disorders. vol 67. 2022-08-07. PMID:35933757. |
transverse myelitis (tm) occurs isolated or within other acquired demyelinating syndromes (ads) such as neuromyelitis optica spectrum disorders (nmosd), multiple sclerosis (ms) or myelin oligodendrocyte glycoprotein antibody associated disorders (mogad). |
2022-08-07 |
2023-08-14 |
Not clear |
| Patrick Murtagh, Amy Coman, Kirk Stephenson, Maria Gaughan, David Ryan, Graeme McNeill, Christopher McGuigan, Lorraine Cassid. Neuromyelitis optica spectrum disorders and anti-myelin oligodendrocyte glycoprotein positive optic neuropathies. International journal of ophthalmology. vol 15. issue 7. 2022-08-03. PMID:35919317. |
neuromyelitis optica spectrum disorders and anti-myelin oligodendrocyte glycoprotein positive optic neuropathies. |
2022-08-03 |
2023-08-14 |
Not clear |